FindTrial
Sign In

Reseach and Application of Transcutaneous Electrical Nerve Stimulation in the Treatment of Drug-resistant Neurogenic Overactive Bladder

Reseach and Application of Transcutaneous Electrical Nerve Stimulation in the Treatment of Drug-resistant Neurogenic Overactive Bladder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009375
Enrollment
Unknown
Registered
2016-10-11
Start date
2016-11-01
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-resistant Neurogenic Overactive Bladder

Interventions

A:TENS
B:Anticholinergic Drugs

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: The patients who taking anticholinergic drugs after 3 months has not been significantly improved neurogenic bladder overactivity.

Exclusion criteria

Exclusion criteria: Patients with urinary retention; patients with overactive bladder in the past due to various reasons (Dementia, urinary tract tumors, urolithiasis, unhealed urinary tract infections, or history of urinary tract surgery); patients who needed significant fluid infusions or drugs that affected urination; patients with concurrent serious organic diseases; patients with severe cognitive functional disorders (Mini-Mental State Examination score < 22 points); patients who were unable to communicate effectively; and patients who were unable to provide accurate survey information or to complete the treatment period.

Design outcomes

Primary

MeasureTime frame
OABSS;—

Countries

China

Contacts

Public ContactLiu Yi

Shanghai Tenth People's Hospital

starry0712@163.com+86 18917684158

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026